Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleResearch Letter

Expanding the Differential During the COVID-19 Pandemic: Fatal West Nile Virus Neuroinvasive Disease

Stephen J. Titus, Robert N. Suter, Anh T. Hoang and Paul A. Figel
The Journal of the American Board of Family Medicine May 2021, 34 (3) 661-662; DOI: https://doi.org/10.3122/jabfm.2021.03.200630
Stephen J. Titus
From the Family Medicine Residency, Baylor University Medical Center, Dallas, TX (SJT, RNS, ATH, PAF); Texas A&M School of Medicine, College Station, Bryan, TX (SJT, RNS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert N. Suter
From the Family Medicine Residency, Baylor University Medical Center, Dallas, TX (SJT, RNS, ATH, PAF); Texas A&M School of Medicine, College Station, Bryan, TX (SJT, RNS).
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anh T. Hoang
From the Family Medicine Residency, Baylor University Medical Center, Dallas, TX (SJT, RNS, ATH, PAF); Texas A&M School of Medicine, College Station, Bryan, TX (SJT, RNS).
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. Figel
From the Family Medicine Residency, Baylor University Medical Center, Dallas, TX (SJT, RNS, ATH, PAF); Texas A&M School of Medicine, College Station, Bryan, TX (SJT, RNS).
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

The ever-evolving pandemic of Coronavirus disease 2019 (COVID-19) has the potential to drown out other viruses continuing to infect communities. To highlight this, we present 2 cases of fatal West Nile virus neuroinvasive disease that occurred within 2 weeks of each other. Since the first positive case of West Nile virus in the United States, there have been 2 epidemics in the past 2 decades, most often occurring in regions of North Texas and Southern California, which have been areas of high-incidence for COVID-19. It is important for the health care provider to recognize diagnostic biases and maintain broad differentials for the patient presenting with fever and other symptoms associated with COVID-19.

  • California
  • Communicable Diseases
  • COVID-19
  • Family Medicine
  • Hospitalists
  • Pandemics
  • Texas
  • West Nile Virus

Introduction

Amid the COVID-19 pandemic, it is important to remember that many viruses, such as West Nile virus (WNV), are still present. WNV infection is usually self-limited. However, less than 1% of cases develop neuroinvasion, which presents in 1 of 3 forms: meningitis, encephalitis, or acute flaccid paralysis. COVID-19 is similar to WNV infection in that they both have a high incidence in the southwestern United States, have a higher virulence pattern in older populations, and can present with the symptoms of fever and altered mental status. To illustrate this, we discuss 2 cases of fatal neuroinvasive WNV in elderly adults that presented within the same week to our service in Dallas, Texas.

Patient case 1

An 88-year-old female with stage III chronic kidney disease (CKD), hypertension, and hyperlipidemia presented with altered mental status, diarrhea, nausea, vomiting, cough, and fever (104°F). The initial workup included polymerase chain reaction (PCR) for the presence of SARS-CoV-2, blood cultures, and urine cultures, all of which were negative. She received empiric ceftriaxone, vancomycin, and acyclovir. Computed tomography (CT) of the head was unremarkable. A lumbar puncture revealed normal glucose, an elevated protein level (77 mg/dL; normal range, 15 mg/dL to 45 mg/dL), and a lymphocytic pleocytosis with a white blood cell count of 68/µL. Cerebral spinal fluid (CSF) cultures and a CSF meningitis panel (Table 1) were unremarkable. Despite treatment, her symptoms persisted. On day 7 of admission, she became bradycardic with a heart rate of 23 and expired. Postmortem, the serum WNV IgM drawn on the second day of admission returned positive, confirming WNV neuroinvasive disease.

View this table:
  • View inline
  • View popup
Table 1.

Pathogens Tested in Meningitis Panel for Patient Case 2

Patient case 2

An 84-year-old female with a history of stroke presented with malaise, weakness most pronounced in the lower extremities, and confusion. Her family reported a recent history of an upper respiratory infection but without known sick contacts, recent travel, fever, or insect bites. The initial workup including complete blood count, complete metabolic panel, thyroid-stimulating hormone, ammonia levels, and SARS-CoV-2 PCR was unremarkable. Empiric acyclovir and broad-spectrum antibiotics were initiated. CT and magnetic resonance imaging (MRI) of the head showed no acute intracranial pathology and nonspecific white matter changes. CSF analysis indicated lymphocytic pleocytosis with normal glucose, elevated protein of 108 mg/dL, and no organisms. A meningitis panel was negative (Table 1). However, the CSF was positive for WNV IgG and IgM. Despite supportive care, the patient expired from WNV encephalitis.

Discussion

These cases contrast a typical and atypical presentation of WNV with neuroinvasion. The first patient presented with typical symptoms of WNV infection, such as fever and gastrointestinal symptoms.1 The second patient presented with only malaise, weakness, and confusion. Both patients were geriatric, presented in the summer months with worsening altered mental status, and had CSF revealing lymphocytic pleocytosis.

Only 20% of those infected with WNV present with fever.1 Insect bites or recent travel in the patient's history should raise clinical suspicion. Initial neuroimaging may be negative as abnormal MRI findings may not be seen for several weeks, if at all.2 As a normal CSF cell count does not exclude WNV encephalitis,3 confirmation of diagnosis can be made by CSF PCR.4

The treatment for WNV is supportive care. Prognosis is related to comorbid conditions, such as diabetes, hypertension, and renal disease, all of which increase the probability of WNV neuroinvasion.5

Conclusion

While health care providers remain vigilant in recognizing COVID-19, we must continue to have an expansive differential that includes WNV, which can reach epidemic levels in the summer and fall. It is important to educate patients on the use of mosquito repellent, long-sleeve clothing, and the removal of standing water to help reduce risks posed by this preventable infectious disease.

Notes

  • This article was externally peer reviewed.

  • Funding: None.

  • Conflict of interest: None.

  • To see this article online, please go to: http://jabfm.org/content/34/3/661.full.

  • Received for publication December 8, 2020.
  • Revision received February 10, 2021.
  • Accepted for publication February 12, 2021.

References

  1. 1.↵
    1. Bai F,
    2. Thompson EA,
    3. Parminder JSV,
    4. Leis AA
    . Current understanding of West Nile virus clinical manifestations, immune responses, neuroinvasion, and immunotherapeutic implications. Pathogens 2019;8:193.
    OpenUrlCrossRef
  2. 2.↵
    1. Sejvar JJ
    . Clinical manifestations and outcomes of West Nile virus infection. Viruses 2014;6:606–23.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Nash D,
    2. Mostashari F,
    3. Fine A,
    4. et al
    . 1999 West Nile Outbreak Response Working Group. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807–14.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Tyler KL,
    2. Pape J,
    3. Goody RJ,
    4. Corkill M,
    5. Kleinschmidt-DeMasters BK
    . CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology 2006;66:361–5.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Bode AV,
    2. Sejvar JJ,
    3. Pape WJ,
    4. Campbell GL,
    5. Marfin AA
    . West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 2006;42:1234–40.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 34 (3)
The Journal of the American Board of Family Medicine
Vol. 34, Issue 3
May/June 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Expanding the Differential During the COVID-19 Pandemic: Fatal West Nile Virus Neuroinvasive Disease
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Expanding the Differential During the COVID-19 Pandemic: Fatal West Nile Virus Neuroinvasive Disease
Stephen J. Titus, Robert N. Suter, Anh T. Hoang, Paul A. Figel
The Journal of the American Board of Family Medicine May 2021, 34 (3) 661-662; DOI: 10.3122/jabfm.2021.03.200630

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Expanding the Differential During the COVID-19 Pandemic: Fatal West Nile Virus Neuroinvasive Disease
Stephen J. Titus, Robert N. Suter, Anh T. Hoang, Paul A. Figel
The Journal of the American Board of Family Medicine May 2021, 34 (3) 661-662; DOI: 10.3122/jabfm.2021.03.200630
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patient case 1
    • Patient case 2
    • Discussion
    • Conclusion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • COVID-19 Pandemic Practices, Payment Models, and Publication Successes: Family Medicine Studies a Variety of Primary Care Questions
  • Google Scholar

More in this TOC Section

  • Timing of Certification Stage Completion Associated with Subsequent Certification Exam Outcomes Among Board-Certified Family Physicians
  • Interpersonal Continuity of Care May Help Delay Progression to Type 2 Diabetes
  • Impact of Point of Care Hemoglobin A1c Testing on Time to Therapeutic Intervention
Show more Research Letter

Similar Articles

Keywords

  • California
  • Communicable Diseases
  • COVID-19
  • Family Medicine
  • Hospitalists
  • Pandemics
  • Texas
  • West Nile Virus

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire